Eleftheria Maratos-Flier Selected Research

Obesity

1/2021	Weight Loss Outcomes Among Early High Responders to Exenatide Treatment: A Randomized, Placebo Controlled Study in Overweight and Obese Women.
11/2017	The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
7/2017	Leptin's Physiologic Role: Does the Emperor of Energy Balance Have No Clothes?
1/2016	Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas.
1/2016	iNKT Cells Induce FGF21 for Thermogenesis and Are Required for Maximal Weight Loss in GLP1 Therapy.
1/2015	The promyelocytic leukemia protein is upregulated in conditions of obesity and liver steatosis.
11/2014	Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
1/2014	Expression of melanin-concentrating hormone receptor 2 protects against diet-induced obesity in male mice.
1/2012	Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice.
4/2011	Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eleftheria Maratos-Flier Research Topics

Disease

28	Obesity 01/2021 - 01/2003
18	Weight Loss (Weight Reduction) 01/2022 - 08/2003
11	Body Weight (Weight, Body) 11/2019 - 01/2004
8	Insulin Resistance 01/2022 - 01/2004
7	Fatty Liver 01/2018 - 06/2007
7	Inflammation (Inflammations) 01/2018 - 05/2008
6	Non-alcoholic Fatty Liver Disease 01/2022 - 05/2010
5	Weight Gain 01/2017 - 11/2009
4	Ketosis 01/2020 - 11/2009
4	Fibrosis (Cirrhosis) 01/2018 - 11/2014
4	Starvation 07/2017 - 11/2009
3	Overweight 01/2021 - 06/2003
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2017
2	Pancreatitis 01/2016 - 01/2016
2	Thinness 12/2007 - 02/2006
1	Hypertriglyceridemia 01/2022
1	Bone Resorption 01/2022
1	Neoplasms (Cancer) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 11/2017
1	Liver Diseases (Liver Disease) 11/2017
1	Binge Drinking 11/2017
1	Atrophy 01/2017
1	Infertility (Sterility) 08/2016
1	Hyperplasia 01/2016
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2016
1	Anorexia Nervosa 10/2015
1	Atherosclerosis 09/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2015
1	Metabolic Diseases (Metabolic Disease) 08/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	Choline Deficiency 11/2014
1	Cognitive Dysfunction 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Hypothermia 02/2012
1	Nausea 01/2012
1	Anosmia 01/2011
1	Type 2 Diabetes Mellitus (MODY) 12/2010

Drug/Important Bio-Agent (IBA)

23	fibroblast growth factor 21IBA 01/2022 - 06/2007
15	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2004
13	LeptinIBA 07/2017 - 01/2003
7	Insulin (Novolin)FDA Link 01/2022 - 10/2004
6	Hormones (Hormone)IBA 07/2017 - 04/2004
5	CarbohydratesIBA 01/2017 - 06/2007
5	melanin-concentrating hormone (melanin concentrating hormone)IBA 07/2008 - 04/2004
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2010
4	LipidsIBA 01/2022 - 06/2007
4	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2018 - 11/2009
4	Peptides (Polypeptides)IBA 01/2016 - 04/2004
4	NeuropeptidesIBA 07/2005 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2010
3	FructoseIBA 11/2017 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 07/2017 - 11/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2014 - 05/2008
3	Messenger RNA (mRNA)IBA 08/2010 - 01/2004
2	Exenatide (Byetta)FDA Link 01/2021 - 01/2012
2	LigandsIBA 01/2016 - 05/2004
2	Methionine (L-Methionine)FDA Link 11/2014 - 01/2013
2	melanin-concentrating hormone receptorIBA 01/2014 - 05/2004
2	Nonesterified Fatty Acids (NEFA)IBA 11/2010 - 10/2004
2	Leptin ReceptorsIBA 07/2010 - 11/2008
2	CytokinesIBA 09/2008 - 05/2008
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	AdiponectinIBA 01/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	C-PeptideIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	vesicular GABA transporterIBA 11/2019
1	Reticulin (Reticular Fiber)IBA 01/2018
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 11/2017
1	beta Adrenergic ReceptorsIBA 01/2017
1	GonadotropinsIBA 08/2016
1	Liraglutide FDA Link 01/2016
1	Lipase (Acid Lipase)FDA Link 01/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016
1	Galactosylceramides (Galactocerebrosides)IBA 01/2016
1	Olanzapine (Zyprexa)FDA Link 10/2015
1	Antipsychotic Agents (Antipsychotics)IBA 10/2015
1	Niacinamide (Nicotinamide)FDA LinkGeneric 08/2015
1	Promyelocytic Leukemia ProteinIBA 01/2015
1	SugarsIBA 01/2015
1	Choline (Choline Chloride)IBA 01/2013
1	CholesterolIBA 01/2013
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2012
1	Agouti-Related ProteinIBA 04/2011
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2011
1	Biological ProductsIBA 12/2010
1	Therapeutic UsesIBA 12/2010

Therapy/Procedure

5	Therapeutics 11/2017 - 04/2005
5	Ketogenic Diet 01/2017 - 06/2007
2	Injections 01/2021 - 06/2003
2	Fat-Restricted Diet (Diet, Fat Restricted) 01/2013 - 10/2004
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 09/2009 - 08/2003
2	Caloric Restriction 12/2007 - 02/2006
1	Drug Therapy (Chemotherapy) 01/2021
1	Bariatric Surgery 11/2017
1	Glycemic Control 01/2016